Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (HKSE: 2566) is trading at HK$5.70, about ₹70 at today's HKD/INR rate, as of 24 Sep 2026, 3:36 AM ET, up 3.73% today. Indian residents can buy Hangzhou Jiuyuan Genetic Biopharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$5.50
Today's high
HK$5.70
52 week low
HK$4.60
52 week high
HK$12.71
2566 opened at HK$5.50, closed previously at HK$5.49, and has traded between HK$4.60 and HK$12.71 over the past 52 weeks.
About
Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices in Mainland China and internationally. The company offers Guyoudao, a bone repair material; Jilifen, a human granulocyte colony stimulating factor injection; Jijufen, a human interleukin-11 injection; Jiouting, a palonosetron hydrochloride injection; Jifuwei, a fulvestrant injection; Jitansu, a fosaprepitant dimeglumine injection; and Jixinfen, PEG-GCSF injection. It also provides Jilixin avatrombopag maleate tablets; Jipailin, a low molecular weight heparin sodium injection; and Yinuojia, an enoxaparin sodium injection. The company was formerly known as Hangzhou Jiuyuan Gene Engineering Co., Ltd. and changed its name to Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. in April 2025. Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. was incorporated in 1993 and is headquartered in Hangzhou, China.
Key statistics
Avg. volume
74.80K
Market cap
HK$1.38B
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
1.30
Dividend yield
—
Last dividend
HK$0.07
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Hangzhou Jiuyuan Genetic Biopharmaceutical from India
Indian residents can buy Hangzhou Jiuyuan Genetic Biopharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Hangzhou Jiuyuan Genetic Biopharmaceutical and place an order
Find Hangzhou Jiuyuan Genetic Biopharmaceutical by name or by its ticker, 2566, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Hangzhou Jiuyuan Genetic Biopharmaceutical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Hangzhou Jiuyuan Genetic Biopharmaceutical position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in Hangzhou Jiuyuan Genetic Biopharmaceutical from India
Trading and taxes when buying Hangzhou Jiuyuan Genetic Biopharmaceutical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Hangzhou Jiuyuan Genetic Biopharmaceutical stock?
Yes. Hangzhou Jiuyuan Genetic Biopharmaceutical (2566) has been listed on the Hong Kong Stock Exchange since 2024, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Hangzhou Jiuyuan Genetic Biopharmaceutical share cost in rupees?
One Hangzhou Jiuyuan Genetic Biopharmaceutical share is HK$5.70 — about ₹70 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Hangzhou Jiuyuan Genetic Biopharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Hangzhou Jiuyuan Genetic Biopharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Hangzhou Jiuyuan Genetic Biopharmaceutical?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Hangzhou Jiuyuan Genetic Biopharmaceutical shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Hangzhou Jiuyuan Genetic Biopharmaceutical price. Paasa issues a capital-gains statement for your return.
Does Hangzhou Jiuyuan Genetic Biopharmaceutical pay a dividend, and how is it taxed in India?
Yes. Hangzhou Jiuyuan Genetic Biopharmaceutical pays a dividend — the most recent was HK$0.07 per share, about ₹0.80. Dividends are taxed at your slab rate in India. Paasa's dividend report covers each payment.
When can I trade Hangzhou Jiuyuan Genetic Biopharmaceutical from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Hangzhou Jiuyuan Genetic Biopharmaceutical a Hong Kong SAR China company, and does that change how it is taxed?
Hangzhou Jiuyuan Genetic Biopharmaceutical trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Hangzhou Jiuyuan Genetic Biopharmaceutical trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Hangzhou Jiuyuan Genetic Biopharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Hangzhou Jiuyuan Genetic Biopharmaceutical holding, its cost and its closing value.
How do I sell Hangzhou Jiuyuan Genetic Biopharmaceutical and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.